Fortress Affiliates Complete Their Acquisition of Finjan

Fortress Affiliates Complete Their Acquisition of Finjan EAST PALO ALTO, Calif. and NEW YORK, July 24, 2020 (GLOBE NEWSWIRE) -- Finjan Holdings, Inc. (“Finjan”) (NASDAQ:FNJN) and affiliates of Fortress Investment Group LLC (such affiliates, collectively “Fortress”) today announced that Fortress has completed its previously announced acquisition of Finjan.  Finjan, a recognized pioneer in the development of cybersecurity technologies, will maintain its brand and business model post-transaction, licensing a substantial patent portfolio that has been consistently upheld by courts and pate...

Finjan Enters into Agreement to be Acquired by Affiliates of Fortress in an All Cash Transaction

Finjan Enters into Agreement to be Acquired by Affiliates of Fortress in an All Cash Transaction EAST PALO ALTO, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- Finjan Holdings, Inc. (NASDAQ: FNJN) (Finjan) today announced that it has entered into a definitive agreement (the “Merger Agreement”) pursuant to which affiliates of Fortress Investment Group LLC (collectively “Fortress”) would acquire all outstanding shares of Finjan common stock for $1.55 per share in cash (the “Transaction”), representing an aggregate equity value of approximately $43.9 million. Finjan, a recognized pioneer in the d...

Finjan and Cisco Patent Infringement Trial Reset to October 19, 2020 Securing Court Calendar for Speedy Criminal Trials

Finjan and Cisco Patent Infringement Trial Reset to October 19, 2020 Securing Court Calendar for Speedy Criminal Trials EAST PALO ALTO, Calif., May 28, 2020 (GLOBE NEWSWIRE) -- Finjan Holdings, Inc. (NASDAQ: FNJN) and its subsidiary Finjan, Inc. (Finjan) announce that its jury trial against Cisco Systems, Inc. (Cisco) previously scheduled for June 22, 2020, has been postponed to October 19, 2020. The case is pending in the U.S. District Court for the Northern District of California (the Court), Case No. 5:17-cv-00072-BLF, before the Honorable Beth Labson Freeman. On May 26, 2020, Judge F...

PBSV: Steady as she goes

BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share...

MNOV: FDA Gives OK to Initiate Clinical Trial of MN-166 to Prevent ARDS in COVID- 19 Patients...